eISSN: 2957-9716 / ISSN: 2957-9708
Register
Login
International Journal of Clinical Studies and Medical Research
2023, Volume 1, Issue 3 : 1-3
Research Article
Long-Term Outcomes After Acute Myocardial Infarction
 ,
 ,
1
Department of Cardiology, Global Heart Institute, Boston, Massachusetts, USA
2
Department of Internal Medicine, National Medical Research University, New Delhi, India
3
Department of Cardiovascular Sciences, International Clinical Research Center, Kuala Lumpur, Malaysia
Abstract

Acute myocardial infarction (AMI) remains one of the leading causes of morbidity and mortality worldwide despite significant advances in cardiovascular care. Improvements in reperfusion therapies, pharmacological interventions, and secondary prevention strategies have substantially increased survival rates following AMI. However, many survivors continue to face long-term complications including recurrent cardiovascular events, heart failure, arrhythmias, reduced quality of life, and increased healthcare utilization. Understanding long-term outcomes after AMI is essential for optimizing patient management, improving survival, and enhancing quality of life. This review examines the epidemiology, determinants, clinical outcomes, risk factors, and management strategies associated with long-term survival after AMI. The study highlights the importance of comprehensive secondary prevention, lifestyle modification, cardiac rehabilitation, medication adherence, and emerging digital health technologies. Findings suggest that multidisciplinary follow-up care and personalized treatment approaches significantly improve long-term prognosis. Future research should focus on precision medicine, artificial intelligence-based risk prediction, and innovative interventions aimed at reducing cardiovascular morbidity among AMI survivors.

Keywords
License
Copyright (c) International Journal of Clinical Studies and Medical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Clin. Stud. Med. Res. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Artificial Intelligence in Clinical Decision-Making: Opportunities and Challenges
1-7
Management Strategies for Multimorbidity in Elderly Patients
1-8
Telemedicine and Its Impact on Chronic Disease Management
1-8
Clinical Outcomes of Personalized Medicine Approaches: Advancing Precision Healthcare Through Genomic and Patient-Centered Interventions
1-2
International Journal of Clinical Studies and Medical Research
support@ijcsmr.co.ke
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Clinical Studies and Medical Research. All rights reserved.
|
|
|